Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
about
Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challengeAttenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive ratsPirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failurePirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapyCytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBDPharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteineNintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosisEfficacy and safety of pirfenidone for idiopathic pulmonary fibrosisUpdate on diagnosis and treatment of idiopathic pulmonary fibrosisReversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic ratsAdverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trialsCellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion.Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin BNew therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosisPirfenidone treatment of idiopathic pulmonary fibrosis.Pirfenidone: an anti-fibrotic therapy for progressive kidney disease.Novel therapeutic approaches for pulmonary fibrosis.Therapeutic targets for treating fibrotic kidney diseasesOral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study.Phenylpyrrolidine structural mimics of pirfenidone lacking antifibrotic activity: A new tool for mechanism of action studies.Dapson in heterocyclic chemistry, part VIII: synthesis, molecular docking and anticancer activity of some novel sulfonylbiscompounds carrying biologically active 1,3-dihydropyridine, chromene and chromenopyridine moieties.Pirfenidone inhibits fibrosis in foreign body reaction after glaucoma drainage device implantationThe bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis.Investigational approaches to therapies for idiopathic pulmonary fibrosis.New approaches to modulating idiopathic pulmonary fibrosis.Role of pirfenidone in the management of pulmonary fibrosis.Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma.Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts.Current Approaches Including Novel Nano/Microtechniques to Reduce Silicone Implant-Induced Contracture with Adverse Immune Responses.
P2860
Q24652737-A4747211-E578-4291-9C59-B2AEAE692A9AQ24673267-510BC28A-2005-413D-859F-E445AA1E2776Q24684669-01FD266B-981B-4B9C-8B95-756C38CCD91CQ26738458-2DE33796-C396-4EFC-8578-1C5030B07A7FQ26740540-3813B330-C2E1-4AF8-97CF-F3D0311A3E72Q26777928-0059B23B-C574-4393-AD55-D24F1DA9585BQ26783169-AF68637F-D88D-46B9-A9CF-A9486D5421EFQ26849378-32C17C91-D273-4C9F-A98F-BAB82500A668Q28083702-20249F47-2C4A-45E7-A528-C393E1874AD2Q28367881-7E68CD7D-C4B5-4537-829E-5D6198B3B670Q28484304-F0F792EC-EA98-4A79-B7AA-4DCFA1A5E46DQ33840143-FD0ABBB5-4BC3-463F-9403-DB251CF1E6E3Q34088175-F5517796-257F-47B9-A84A-ABD4970EE27AQ34123201-D24D6285-677A-44DE-9DD9-31DC44940680Q34432217-AF4DCFC5-8F43-4B86-A72E-D54D44814BB6Q34503157-EA77E7D1-DB13-4EF5-8400-B1087DA5494FQ34574174-91D64A2C-1B1A-4238-B14C-F2A7E7A51A98Q34680788-55A6A07A-3CF8-45A7-BC3D-4AB1F5C99592Q34903224-C14FBC87-9751-4DE8-A33F-5E019E428271Q35079607-69DADE86-4757-4734-A9A3-E3A1BE9B589BQ35840642-C1EF9EC7-2C6F-4B79-AC9D-34B147995A87Q36391459-ADA831DA-8FE3-49E7-BA33-CC0B20996866Q36527362-5894D27F-F40F-4E4B-A572-A6B034E81B4CQ36826817-9C3FEEB9-0012-4AA5-9DC6-55D055B2BC4AQ36970923-5F5ABCE4-AD6D-4D79-910C-D64176F033A2Q37080510-57D0700A-85B7-47F1-983A-3B46A425E715Q37628170-FE1A61C2-1722-4B66-BC9B-BDDC0C0C8815Q37742646-8ABE49DC-35EF-44D2-AEAA-F64952F47A4AQ38130161-B76DB71D-2FB7-4149-A2D3-E43AE6836522Q39257627-3C619741-4746-4989-8E02-5EF5C5FE97F9Q40044336-E6179740-7CA8-4892-BFAE-EDB65625BD75Q47712367-D0802E7A-3314-4947-9147-058FFD582D6CQ52591902-4E5E7287-FFD3-4F1D-A8BD-6BABD95F6A72
P2860
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@ast
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@en
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@nl
type
label
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@ast
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@en
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@nl
prefLabel
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@ast
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@en
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@nl
P2093
P1476
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
@en
P2093
P304
P577
1995-06-01T00:00:00Z